Eosinopenia is a reliable marker of severe disease and unfavourable outcome in patients with COVID-19 pneumonia.

Massimo Cazzaniga Luca Andrea Mario FumagalliLuciano D'angeloMario CerinoGiulia BonfantiRiccardo M FumagalliGianpaolo SchiavoCristina LoriniElisa LainuSabina TerragniMarco ChiarelliClaudio ScarazzatiClaudio BonatoMauro Zago

Published in: International journal of clinical practice (2021)

Absolute eosinopenia is associated with clinical outcomes in patients with COVID-19 pneumonia and might be used as a marker to discriminate patients with unfavourable prognosis.

Keyphrases

respiratory failure
community acquired pneumonia
early onset
intensive care unit
drug induced
acute respiratory distress syndrome